Patents by Inventor Adrian L. Krag

Adrian L. Krag has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8696991
    Abstract: An apparatus and method for detection of anything to which an antibody can be raised, or to which a chemical receptor can be fashioned, based on surface plasmon resonance. The apparatus and method have the capability to detect proteins, viruses, bacteria, toxins, pathogens, contaminants, chemical compounds, or nucleic acids based on surface plasmon resonance and surface receptor technologies which may include antibodies or chemical receptors. The device is field deployable and utilizes a single use sample holder card which includes the sample to be tested, test channels, waste reservoir and a functionalized test surface.
    Type: Grant
    Filed: January 4, 2011
    Date of Patent: April 15, 2014
    Inventors: Harold W. Howe, Timothy S. Troutman, Michael E. Meichle, Adrian L. Krag
  • Publication number: 20100305551
    Abstract: A drug-delivery unit suitable for implantation into a patient body may include a valveless impedance pump. In some implementations the unit may include an actuator, control electronics and a battery, and may communicate with an external patient interface unit. The patient interface unit can be used to control operation of the implant and to download data from the implant. The patient interface unit can also be used to charge the implant and/or a separate charger can be used. In other implementations, a drug-delivery implant unit may lack internal electronics and instead rely on an externally-supplied magnetic field to actuate the pump.
    Type: Application
    Filed: June 4, 2010
    Publication date: December 2, 2010
    Applicant: NEUROSYSTEC CORP.
    Inventors: Thomas J. Lobl, Jacob E. Pananen, David L. Canfield, Anna I. Nagy, Adrian L. Krag
  • Publication number: 20090209945
    Abstract: A drug-delivery unit suitable for implantation into a patient body may include a valveless impedance pump. In some implementations the unit may include an actuator, control electronics and a battery, and may communicate with an external patient interface unit. The patient interface unit can be used to control operation of the implant and to download data from the implant. The patient interface unit can also be used to charge the implant and/or a separate charger can be used. In other implementations, a drug-delivery implant unit may lack internal electronics and instead rely on an externally-supplied magnetic field to actuate the pump.
    Type: Application
    Filed: January 19, 2009
    Publication date: August 20, 2009
    Applicant: NEUROSYSTEC CORPORATION
    Inventors: Thomas J. Lobl, Jacob E. Pananen, David L. Canfield, Anna I. Nagy, Adrian L. Krag